Prime Medicine Inc header image

Prime Medicine Inc

PRME

Equity

ISIN null / Valor 122054714

NASDAQ (2025-12-24)
USD 3.57-3.25%

Prime Medicine Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Prime Medicine Inc is a biotechnology company focused on utilizing their innovative Prime Editing platform to address genetic diseases at their root cause. Their technology aims to replace faulty DNA with correct copies, potentially offering long-lasting cures for patients. Prime Editing is designed to be versatile, precise, and efficient, with the capability to target a wide range of disease-causing mutations across various organisms, organs, and cell types. The company believes that their approach will significantly enhance the impact of gene editing in therapeutic applications.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

29.3%1Y
-80.0%3Y
%5Y

Performance

112%1Y
90.5%3Y
91.0%5Y

Volatility

Market cap

644 M

Market cap (USD)

Daily traded volume (Shares)

2,288,228

Daily traded volume (Shares)

1 day high/low

2.895 / 2.745

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Immunovant Inc
Immunovant Inc Immunovant Inc Valor: 51661055
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%USD 26.88
AdCapital AG
AdCapital AG AdCapital AG Valor: 324972
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.76%EUR 1.28
Marqeta Inc
Marqeta Inc Marqeta Inc Valor: 111668156
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.80%USD 4.93
Siemens AG
Siemens AG Siemens AG Valor: 827766
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.49%EUR 237.80
AIXTRON SE
AIXTRON SE AIXTRON SE Valor: 4566068
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.71%EUR 17.13
Progress Software Corp
Progress Software Corp Progress Software Corp Valor: 963966
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 42.83
Maravai LifeSciences Holdings Inc
Maravai LifeSciences Holdings Inc Maravai LifeSciences Holdings Inc Valor: 58353451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.30%USD 3.30
Grand Canyon Education Inc
Grand Canyon Education Inc Grand Canyon Education Inc Valor: 4243864
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.02%USD 168.21
TTM Technologies Inc
TTM Technologies Inc TTM Technologies Inc Valor: 1127815
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.40%USD 72.59
Vericel Corp
Vericel Corp Vericel Corp Valor: 26056775
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 37.56